top of page
Prescription Drugs


Who We Are

Penta Pharma Egypt is a dynamic generic pharmaceutical joint stock company based in Egypt with a diverse and experienced team. Our extensive generics portfolio, approved by the Egyptian Drug Authority (EDA), covers a diverse range of therapeutic areas, including oncology, respiratory, neurology, cardiovascular, diabetes, gastroenterology, hepatology, dermatology, skeletomuscular, analgesics, anti-viral, and lifestyle medications for weight management, erectile dysfunction and premature ejaculation. With a focus on quality, innovation, and affordability, we offer various dosage forms, including tablets, capsules, injectables, creams, ointments, nasal drops, solutions, and suspensions.​

Manufacturing Excellence

Our state-of-the-art manufacturing facility, located in Ismailia's Abu Sultan industrial zone, is the backbone of our commitment to quality. Specializing in solid and semi-solid preparations, our production lines adhere to the highest international standards. With an ambitious plan to add more production lines and introduce additional dosage forms, we continuously strive to expand our capabilities. Our manufacturing site received positive audits from the Ministry of Health and Population in Egypt and other countries in Africa and the Middle East, such as Iraq, Yemen, Sudan, Libya, and Congo. The site also received an ISO 9001 certification, showcasing our dedication to excellence.

EDA-Approved Quality

At Penta Pharma Egypt, we are committed to manufacturing and marketing the most updated portfolio of EDA-approved generic products. Our dedication to quality extends to having one of the largest generic pipelines in the region, ensuring a continuous supply of innovative and effective medications.

Patient-Centric Approach

Understanding the importance of making safe and quality medications accessible to all, we operate with a patient-centric approach. By prioritizing the needs of our patients, we aim to contribute to the well-being of individuals across Egypt and beyond.​

bottom of page